{"title":"研究:FDG PET/CT成像在乳腺癌随访中的作用:我们的机构经验","authors":"Selma Agić-Bilalagić, A. Begić, Miran Hadćiahmetović, Šejla Cerić, Amila Bašić, Ajla Arnautović-Halimić","doi":"10.18689/mjcr-1000110","DOIUrl":null,"url":null,"abstract":"Methods: We studied 87 female patients with breast cancer that were referred for an FDG-PET/CT scan because of elevated tumor markers and negative or equivocal findings in conventional imaging studies. PET/CT images from January 2018 to March 2019 were respectively reviewed. All imaging was done at Clinic for Nuclear Medicine, Clinical Centre University of Sarajevo. All patients underwent a whole-body FDG-PET/CT scan in a combined PET/CT imaging.","PeriodicalId":132259,"journal":{"name":"Madridge Journal of Clinical Research","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Study: Role of FDG PET/CT imaging in follow up of Breast Cancer: Our Institutional Experience\",\"authors\":\"Selma Agić-Bilalagić, A. Begić, Miran Hadćiahmetović, Šejla Cerić, Amila Bašić, Ajla Arnautović-Halimić\",\"doi\":\"10.18689/mjcr-1000110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Methods: We studied 87 female patients with breast cancer that were referred for an FDG-PET/CT scan because of elevated tumor markers and negative or equivocal findings in conventional imaging studies. PET/CT images from January 2018 to March 2019 were respectively reviewed. All imaging was done at Clinic for Nuclear Medicine, Clinical Centre University of Sarajevo. All patients underwent a whole-body FDG-PET/CT scan in a combined PET/CT imaging.\",\"PeriodicalId\":132259,\"journal\":{\"name\":\"Madridge Journal of Clinical Research\",\"volume\":\"12 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Madridge Journal of Clinical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18689/mjcr-1000110\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Madridge Journal of Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18689/mjcr-1000110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Study: Role of FDG PET/CT imaging in follow up of Breast Cancer: Our Institutional Experience
Methods: We studied 87 female patients with breast cancer that were referred for an FDG-PET/CT scan because of elevated tumor markers and negative or equivocal findings in conventional imaging studies. PET/CT images from January 2018 to March 2019 were respectively reviewed. All imaging was done at Clinic for Nuclear Medicine, Clinical Centre University of Sarajevo. All patients underwent a whole-body FDG-PET/CT scan in a combined PET/CT imaging.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
